UnicoCell
Toggle navigation
About
Cell Therapy
Products & services
News
Contact
中文
/
EN
News
2023.8.15 UnicoCell received Acknowledgment letter of MF (Master File) from US FDA for UnicoCell Conditioned Medium (UCCM)
2023.7.10 Unicocell Biomed Enrolls First Participant in Phase III Clinical Trial for Knee Osteoarthritis
2023.3.31 Unicocell Biomed Joins Taiwan Extracellular Vesicle Industry-Academia Association as a Member of the STEERING COMMITTEE
2023.3.3 Unicocell Biomed Knee Osteoarthritis Treatment Receives FDA approval for Phase III Clinical Trial
2023.2.14 Unicocell Biomed New Drug Receives Certification from SNQ
2023.2.8 Approval Granted for Unicocell Biomed to Initiate Phase III Clinical Trial for Knee Osteoarthritis Treatment
Products & services
Conditioned Medium
MORE
Mass Production and CDMO
MORE
Autologous Stem Cell Therapy
MORE
Allogeneic Adipose Stem Cell Bank
MORE